Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
RGEN

Market Cap: $9.32B

RC

Repligen Corporation

RGEN

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin51.05%

EBITDA Margin15.52%

EBIT Margin9.87%

Pre-tax Margin6.64%

Net Profit Margin5.29%

Earnings Yield0.45%

Valuation Multiples

Price / Book4.41

Price / Sales11.87

Price / Earnings223.22

PEG0.27

Forward PEG8.02

EV / Sales11.98

EV / EBITDA77.21

EV / Operating Cash Flow69.75

EV / Free Cash Flow84.91

Price / Free Cash Flow84.15

Price / Operating Cash Flow69.06

Cash Flow & Capital

Free Cash Flow / Share$1.96

Operating Cash Flow / Share$2.39

Free Cash Flow Yield1.19%

Capex / Revenue3.07%

Capex / Operating Cash Flow17.86%

Capex / Depreciation0.27

Stock Compensation / Revenue4.24%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio9.05

Quick Ratio7.64

Cash Ratio4.57

Debt / Assets0.23

Debt / Capital0.25

Debt / Equity0.33

Long-Term Debt / Capital0.21

Debt / Market Cap5.91%

Net Debt / EBITDA0.69

Solvency Ratio0.10

Financial Leverage1.40

Efficiency & Working Capital

Asset Turnover0.27

Fixed Asset Turnover2.77

Inventory Turnover2.06

Receivables Turnover4.98

Payables Turnover11.56

Days Sales Outstanding73.32

Days Inventory Outstanding177.23

Days Payables Outstanding31.56

Operating Cycle250.55

Cash Conversion Cycle218.99

Working Capital Turnover0.75

Returns & Quality

Return on Equity1.98%

Return on Assets1.41%

Return on Invested Capital1.83%

ROCE2.32%

Return on Tangible Assets2.79%

Operating Return on Assets2.22%

Income Quality3.25

Tax Burden0.80

Interest Burden0.67

Balance Sheet & Intrinsic Metrics

Enterprise Value$9.41B

Invested Capital$2.81B

Working Capital$1.07B

Tangible Asset Value$650.23M

Net Current Asset Value$362.41M

Graham Number$24.92

Graham Net-Net$3.26

Book Value / Share$37.46

Tangible Book Value / Share$11.53

Cash / Share$14.37

Financial Health Scores

Piotroski Score7

Altman Z-Score7.66

Revenue$785.1M

EBIT$77.47M

Market Cap$9.29B

Working Capital$1.07B

Retained Earnings$469.59M

Total Assets$2.95B

Total Liabilities$838.15M